Shenzhen Bingbing Paper Ltd. – Trademark Portfolio
Entity Type: 16
Shenzhen Bingbing Paper Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include M BEAUTY and GLORY GIRL. The owner is based in Shenzhen.
Rm.801,802 and 812,8F, NO.1 Office Block
Vanke Honor Mansion, Buji St., Longgang
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Bingbing Paper Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Shenzhen Bingbing Paper Ltd. have?
Shenzhen Bingbing Paper Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Shenzhen Bingbing Paper Ltd. file in?
Shenzhen Bingbing Paper Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Shenzhen Bingbing Paper Ltd.'s most well-known trademarks?
Shenzhen Bingbing Paper Ltd.'s registered trademark portfolio includes well-known marks such as M BEAUTY and GLORY GIRL. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen Bingbing Paper Ltd.'s trademark registration success rate?
Shenzhen Bingbing Paper Ltd. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.